Biography:

Dr Sharmin Jahan has completed her MBBS at the age of 23 years from  Sir Salimullah Medical College and  Mitford Hospital and postgraduation study MCPS And FCPS from BCPS. She is the Consultant of Dermatology and venereology  of Bangladesh Ministry of Health and family welfare. She has published 1 papers in reputed journal.

Abstract:

Background: Ciclopirox is a broad-spectrum antifungal agent as well as anti-inflammatory agent and is effective against both Gram-positive and Gram-negative bacteria. These properties may give ciclopirox an advantage over other antifungal agents in the treatment of dermatophyte infection.

Objective: To evaluate the efficacy and safety of Ciclopirox olamine 1% cream  in the treatment of Dermatophytosis. 

Methods: In Dhaka Medical College hospital Eighty-one patients with tinea corporis/tinea cruris were selected according to the inclusion and exclusion criteria and were examined for clinical diagnosis  and confirmed by a positive 10.0% KOH reading. They were advised to apply Ciclopirox olamine 1% cream once daily for 2 weeks  and Clinical and mycological  assessment at baseline and at 4^th week.

Result: The age of the patients ranged from 18 to 60 years with the mean age of 32.5 (SD ± 10.5) years. There were 52 (64.2%) male and 29 (35.8%) female with a male to female ratio  was 1.8:1. The mean age of the female patients was significantly lower (Z=1.114; p>0.05) and  highest 29 (35.8%) patients were in the age group of 21-30 years. Tinea corporis found in 47 (58.0%)  and  tinea cruris in 34 (42.0%) . The mean clinical assessment  score declined from 6.6 ± 1.3 at baseline; to 3.9±1.2 at week 1, 0.9 ±1.3 at week 2; 0.7 ± 1.1 at week 4.  Global response was clear in 55 (67.9%) , good in 25 (30.9%)  and fair in 55 (67.9%) . Mycological response was eradicated in 80 (98.8%) patients and persistent in only 1 (1.2%) patients. Clinical efficacy was cure in 55 (67.9%), improvement in 25 (30.9%) and failure in 1 (1.2%). Excessive pruritus occurred  in 2 (2.5%)  and excessive burning in 1 (1.2) after initial application of cream which gradually disappeared after subsequent application.

Biography:

Danny helps aesthetic clinics get repeat visits from patients, so you grow fast without the headache of costly online leads” With over 19 years’ experience, he is one of the UK’s top email marketing experts, helping aesthetic clinics generate new business through their email list.

He has broad experience working in many sectors, with a special interest in aesthetic medicine, supporting clinics and med-spas across the UK, USA and Australia. As well as helping businesses build their sales pipeline, Danny is a sought-after speaker who regularly addresses conferences and seminars on how email can be used for customer acquisition.

Abstract:

Promoting your aesthetic practice online can be tough, especially when you operate in a crowded market. Advertising online is expensive, and frequently, the only result you get is price shoppers and time wasters. So how do you attract quality patients online?

During this workshop Danny Bermant will be demonstrating the one change you need to make to your online marketing to ensure your clinic is fully booked; a change that requires £0 spend on advertising and will result in you catapulting ahead of all your competitors.

Here are some of the specifics that Danny will cover:

• Why online advertising doesn’t always bring in the best leads
• The best people to target online if you want to attract new sales
• Why email is so important for bringing new patients on board
• The single biggest mistake that clinics make with their email marketing
• The exact process you need to follow if you want to turn new leads into customers

Biography:

Dr. Pei Swam Ng, as a proud dean list graduate of Bachelor of medicine and Bachelor of Medicine (MBBS) from University of Malaya, Kuala Lumpur. She obtained the Medical Asethetic Certificate (MAC) and she was also trained locally and abroad. She is an expert in anti-aging solution and main area of interests are regenerative medicine (stem cell, PRP and bioidentical hormone therapy) and facial injectables.

Abstract:

Introduction PRP is a cutting-edge form of regenerative medicine that has widely used for aesthetic medicine. Despite increasing in popularity, there is still lacking of evidence support due to the lack of consistent method in application. Objective To assess the clinical efficacy and patient satisfaction of a 3-months PRP treatment regime for facial rejuvenation in different age group patients. Method 51 patients ranging from 20 to 59 years of age were recruited for this study. They were divided into two groups according to their age: Group A (20-39 years of age) included 20 patients and Group B (40-59 years of age) included 31 patients. Written consent was taken. All patients received total six sessions of PRP treatment at 2-week interval. Nine mililitre of PRP were injected into 8 standardized points. Assessment was carried out using Severity Rating Scale (WSRS) and Global Aesthetic Improvement Scale (GAIS). Patients were followed up for 6 months. Result 15 of 20 patients from Group A while 20 of 31 patients from Group B showed significant improvement in both WSRS and GAIS assessment. Group A patients resulted higher satisfaction level in their appearance. Safety profile of PRP treatment was excellent with minimal downtime. Conclusion 3-months PRP treatment regime is effective and safe for facial rejuvenation resulting high satisfaction level on both age group patients. This treatment regime could be considered as an effective procedure for skin maintenance.

Biography:

Abstract:

Background and Aim: The bone cells (osteocytes and osteoclasts) do not replicate and thus the maintenance of a healthy bone must rely on an exogenous source of cells. Currently, bone fracture management is effectively done by surgeons and the healing process post-operation relies mostly on self-recovery. In view of the aforementioned inadequacies regarding bone regeneration, we opted to test the efficacy of Vitamin D₃ known to induce bone formation post-operation.

Methods: Rat adipose derived mesenchymal stem cells (RADMSCs) were purchased and cultured for 7 and 14 days. The cells were treated with different concentrations of the Vitamin D₃ metabolites/compounds in vitro. Markers of osteoblast differentiation were measured using RT-PCR, ELISA, histology and immunohistochemistry.

Results: Treatment of MSCs with Vitamin D₃ induced early expression of bone markers mRNA levels in relation to untreated control. A higher induction capacity from the metabolites on bone markers was observed when compared to the positive control BMP-2. Immunostaining and histological assays were in support of the bone markers quantitative assays.

Conclusion: Up to now, evidence in support of the idea of using vitamin D₃ and calcium to stimulate differentiation of RADMSCs into bone cells for potential bone healing and accelerate bone quality and quantity is limited. The study findings prove the hypothesis that Vitamin D₃ can be used for bone rehabilitation have the capacity to induce osteoblast differentiation from MSCs; and these cells may be used during transplantation in bone defects.